Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

The fate of CD4+ T cells under tolerance-inducing stimulation: a modeling perspective.

Caridade M, Oliveira VG, Agua-Doce A, Graca L, Ribeiro RM.

Immunol Cell Biol. 2013 Nov-Dec;91(10):652-60. doi: 10.1038/icb.2013.63. Epub 2013 Oct 22.

PMID:
24145855
2.

Tremelimumab (anti-CTLA4) mediates immune responses mainly by direct activation of T effector cells rather than by affecting T regulatory cells.

Khan S, Burt DJ, Ralph C, Thistlethwaite FC, Hawkins RE, Elkord E.

Clin Immunol. 2011 Jan;138(1):85-96. doi: 10.1016/j.clim.2010.09.011. Epub 2010 Nov 5.

PMID:
21056008
3.

CD52 ligation induces CD4 and CD8 down modulation in vivo and in vitro.

Shah A, Lowenstein H, Chant A, Khan A.

Transpl Int. 2006 Sep;19(9):749-58.

5.

Role of double-negative regulatory T cells in long-term cardiac xenograft survival.

Chen W, Ford MS, Young KJ, Cybulsky MI, Zhang L.

J Immunol. 2003 Feb 15;170(4):1846-53.

6.

Bag-1 up-regulation in anti-CD4 mAb treated allo-activated T cells confers resistance to apoptosis.

Sawitzki B, Lehmann M, Vogt K, Risch K, Brock J, Kupiec-Weglinski JW, Volk HD.

Eur J Immunol. 2002 Mar;32(3):800-9.

7.

CD40 ligand blockade induces CD4+ T cell tolerance and linked suppression.

Honey K, Cobbold SP, Waldmann H.

J Immunol. 1999 Nov 1;163(9):4805-10.

8.

Anti-CD4-mediated selection of Treg in vitro - in vitro suppression does not predict in vivo capacity to prevent graft rejection.

Oliveira V, Sawitzki B, Chapman S, Appelt C, Gebuhr I, Wieckiewicz J, Long E, Wood KJ.

Eur J Immunol. 2008 Jun;38(6):1677-88. doi: 10.1002/eji.200737562.

9.

Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.

Shen X, Niu C, König R.

Cell Immunol. 2013 Apr;282(2):117-28. doi: 10.1016/j.cellimm.2013.05.002. Epub 2013 May 15.

PMID:
23770721
10.

Peripheral deletion after bone marrow transplantation with costimulatory blockade has features of both activation-induced cell death and passive cell death.

Wekerle T, Kurtz J, Sayegh M, Ito H, Wells A, Bensinger S, Shaffer J, Turka L, Sykes M.

J Immunol. 2001 Feb 15;166(4):2311-6.

11.

Anti-human CD4 induces peripheral tolerance in a human CD4+, murine CD4-, HLA-DR+ advanced transgenic mouse model.

Laub R, Brecht R, Dorsch M, Valey U, Wenk K, Emmrich F.

J Immunol. 2002 Sep 15;169(6):2947-55.

13.

Thymus-dependent, anti-CD4-induced tolerance to rat cardiac allografts.

Jaques BC, Ahmiedat H, Alastair Gracie J, Marshall HE, Middleton SE, Bolton EM, Bradley JA.

Transplantation. 1998 Nov 27;66(10):1291-9.

PMID:
9846511
14.

Mechanisms of tolerance induced by donor-specific transfusion and ICOS-B7h blockade in a model of CD4+ T-cell-mediated allograft rejection.

Sandner SE, Clarkson MR, Salama AD, Sanchez-Fueyo A, Yagita H, Turka LA, Sayegh MH.

Am J Transplant. 2005 Jan;5(1):31-9.

15.

Differential susceptibility to monomeric HIV gp120-mediated apoptosis in antigen-activated CD4+ T cell populations.

Tuosto L, Gilardini Montani MS, Lorenzetti S, Cundari E, Moretti S, Lombardi G, Piccolella E.

Eur J Immunol. 1995 Oct;25(10):2907-16.

PMID:
7589091
16.

Role for thymic and splenic regulatory CD4+ T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment.

Chiffoleau E, Bériou G, Dutartre P, Usal C, Soulillou JP, Cuturi MC.

J Immunol. 2002 May 15;168(10):5058-69.

18.

Induction of self-antigen-specific Foxp3+ regulatory T cells in the periphery by lymphodepletion treatment with anti-mouse thymocyte globulin in mice.

Lu Y, Suzuki J, Guillioli M, Umland O, Chen Z.

Immunology. 2011 Sep;134(1):50-9. doi: 10.1111/j.1365-2567.2011.03466.x. Epub 2011 Jun 29.

19.

In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.

Tsang J, Jiang S, Tanriver Y, Leung E, Lombardi G, Lechler RI.

Int Immunopharmacol. 2006 Dec 20;6(13-14):1883-8. Epub 2006 Sep 1.

PMID:
17161341
20.

CpG DNA inhibits CD4+CD25+ Treg suppression through direct MyD88-dependent costimulation of effector CD4+ T cells.

LaRosa DF, Gelman AE, Rahman AH, Zhang J, Turka LA, Walsh PT.

Immunol Lett. 2007 Feb 15;108(2):183-8. Epub 2007 Jan 18.

Supplemental Content

Support Center